Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 11,650 | 9,730 | 8,207 | 7,101 | 4,911 |
| Operating Income | -11,650 | -9,730 | -8,207 | -7,101 | -4,911 |
| Other Income | 4,143 | -3,893 | -4,151 | 621 | 1 |
| Pre-tax Income | -7,507 | -13,623 | -12,358 | -6,480 | -4,910 |
| Net Income Continuous | -7,507 | -13,623 | -12,358 | -6,480 | -4,910 |
| Minority Interests | -733 | N/A | 0 | N/A | N/A |
| Net Income | $-6,774 | $-13,623 | $-12,358 | $-6,480 | $-4,910 |
| EPS Basic Total Ops | -699.30 | -1,660.84 | -1,486.01 | -786.71 | -699.30 |
| EPS Basic Continuous Ops | -763.25 | -1,637.16 | -1,486.43 | -801.01 | -734.25 |
| EPS Diluted Total Ops | -1,048.95 | -1,660.84 | -1,486.01 | -786.71 | -699.30 |
| EPS Diluted Continuous Ops | -749.22 | -1,637.16 | -1,486.43 | -801.01 | -734.25 |
| EBITDA(a) | $-11,630 | $-9,719 | $-8,199 | $-7,094 | $-4,905 |